![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Belmont, Surrey, United Kingdom (N.E.W., W.J.C., R.R., Y.M.N., W.A., P.W.S., S.A.E., F.I.R.); and Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Laboratories, The Institute of Cancer Research, London, United Kingdom (N.P.J., M.K.)
Phosphoinositide-specific phospholipase C (PLC) is a key enzyme in the regulation of Ca2+ release from inositol 1,4,5-triphosphate-sensitive stores. U73122
[GenBank]
(1-(6-((17ß-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione) has been extensively used as a pharmacological inhibitor of PLC to elucidate the importance of this enzyme family in signal transduction pathways. U73122
[GenBank]
has an electrophilic maleimide group, which readily reacts with nucleophiles such as thiols and amines. In the current study the conjugation of U73122
[GenBank]
to common components of cell culture medium, namely L-glutamine, glutathione, and bovine serum albumin (BSA), was demonstrated. The half-life of U73122
[GenBank]
on incubation with phosphate-buffered saline (PBS), Hanks' buffered saline solution (with 2 mM glutamine), optimized basal nutrient medium (MCDB131, without BSA), complete medium, Dulbecco's modified Eagle's medium (with 2 mM L-glutamine) was
150, 60, 32, 30, and 18 min, respectively. However, U73122
[GenBank]
was not recoverable from medium supplemented with 0.5% BSA. U73122
[GenBank]
underwent hydrolysis of the maleimide group when incubated with PBS. Glutamine conjugates of U73122
[GenBank]
were identified in cell culture medium. Furthermore, the inhibition of epidermal growth factor-stimulated Ca2+ release in a human epidermoid carcinoma cell line (A431) by U73122
[GenBank]
was substantially reduced by the presence of BSA in a time-dependent manner. In complex cellular assays, the availability of U73122
[GenBank]
to inhibit PLC may be limited by its chemical reactivity and lead to the misinterpretation of results in pharmacological assays.